A clinical study of the long-term therapeutic effects of low-dose erythromycin in diffuse panbronchiolitis--with special reference to changes in tumor-associated carbohydrate antigens in serum

We investigated the long-term (3-30 months) therapeutic effects of low-dose (300-600 mg/day) erythromycin in 26 patients with diffuse panbronchiolitis (DPB). Significant improvements of pulmonary functions especially in %VC and PaO2 as well as respiratory symptoms were shown. However, erythromycin t...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Nihon Kyōbu Shikkan Gakkai zasshi 1992-05, Vol.30 (5), p.802-807
Hauptverfasser:	Mukae, H, Komori, K, Morikawa, N, Sakito, O, Oda, H, Senju, R, Fukushima, K, Hiratani, K, Kadota, J, Hara, K
Format:	Artikel
Sprache:	jpn
Schlagworte:	Adolescent Adult Antigens, CD - blood Antigens, Tumor-Associated, Carbohydrate - blood Bronchiolitis - drug therapy Bronchiolitis - immunology Erythromycin - administration & dosage Female Humans Lewis X Antigen - blood Male Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!